Fenofibrate-promoted hepatomegaly and liver regeneration are PPARα-dependent and partially related to the YAP pathway
Fenofibrate, a peroxisome proliferator-activated receptor α (PPARα) agonist, is widely prescribed for hyperlipidemia management. Recent studies also showed that it has therapeutic potential in various liver diseases. However, its effects on hepatomegaly and liver regeneration and the involved mechan...
Saved in:
Main Authors: | Shicheng Fan (Author), Yue Gao (Author), Pengfei Zhao (Author), Guomin Xie (Author), Yanying Zhou (Author), Xiao Yang (Author), Xuan Li (Author), Shuaishuai Zhang (Author), Frank J. Gonzalez (Author), Aijuan Qu (Author), Min Huang (Author), Huichang Bi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Constitutive androstane receptor induced-hepatomegaly and liver regeneration is partially via yes-associated protein activation
by: Yue Gao, et al.
Published: (2021) -
Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
by: Tong Zhou, et al.
Published: (2022) -
Fenofibrate Decreases Ethanol-Induced Neuroinflammation and Oxidative Stress and Reduces Alcohol Relapse in Rats by a PPAR-α-Dependent Mechanism
by: Cristina Ibáñez, et al.
Published: (2023) -
YAP regulates the liver size during the fasting-refeeding transition in mice
by: Xuan Li, et al.
Published: (2023) -
Hepatomegaly as the first symptom of malignant solid tumors in children
by: Karolina Widłak, et al.
Published: (2018)